(Q73231186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

main subject

phase I clinical trial

1 reference

1 reference

Michael G E O'Rourke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Maree Johnson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Catherine Lanagan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Janet See

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Jie Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

John R Bell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Greg J Slater

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Beverley M Kerr

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Beth Crowe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

David M Purdie

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Suzanne L Elliott

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Kay A O Ellem

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Christopher W Schmidt

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

8 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

387-395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682787%20AND%20SRC:MED&resulttype=core&format=json